Mazzella Antonio, Maiolino Elena, Maisonneuve Patrick, Loi Mauro, Alifano Marco
Thoracic Surgical Department, Cochin Academic Hospital, APHP, Université de Paris, 75014 Paris, France.
Division of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Cancers (Basel). 2023 Mar 20;15(6):1854. doi: 10.3390/cancers15061854.
Our goal was to investigate if and how pre-operative inflammatory status can influence the long-term prognosis of patients undergoing lung surgery for cancer. This prospective observational study includes the agreement of all operable patients to the study, who were referred to our department between 1 January 2017 and 30 December 2018. The inflammatory pre-operative status of the patients was investigated by calculating albumin, CPR (c-protein reactive), complete blood count (neutrophils, lymphocytes, platelets, hemoglobin), and some other indexes referring to inflammatory status, namely the HALP amalgamated index, platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocytes ratio (NLR), systemic immune-inflammation index (SII), and advanced lung cancer inflammation Index (ALI). The follow-up ended in November 2021. Patient overall survival was assessed using the Kaplan-Meier method. The log-rank test was used to compare survival rates. Variables significantly associated with survival at univariate analysis were entered int Cox multivariate analysis (stepwise mode) to assess their independent character. Hazard ratios and their 95% confidence intervals were calculated. Variables associated with < 0.05 were considered significative. : We enrolled 257 patients in our study. The overall survival of the cohort was as follows: 1 year, 96.1%; 3 year, 81.3%; and 4 year, 74.2%. Univariate analysis showed risk factors for overall survival as follows: Thoracoscore ≥ 2 ( = 0.002); histology ( = 0.002); HALP < 32.2 ( = 0.0002); SII ≥ 808.9 ( = 0.0004); ALI < 34.86 ( = 0.0005); NLr ≥ 2.29 ( = 0.01); hemoglobin < 13 g/dl ( = 0.01); PLR ≥ 196.1 ( = 0.005); pN+ ( < 0.0001); pleural invasion ( = 0.0002); and presence of vascular or lymphatic tumor emboli ( = 0.0002). Multivariate Cox analysis (stepwise model) identified Thoracoscore ≥ 2 ( = 0.02); histology, HALP < 32.2 ( = 0.004), and pN ( < 0.0001) as independent predictors of death. Pre-operative inflammatory status strongly influences long-term prognosis in patients affected by NSCLC and undergoing surgery.
我们的目标是研究术前炎症状态是否以及如何影响接受肺癌手术患者的长期预后。这项前瞻性观察性研究纳入了所有可手术患者对该研究的同意,这些患者于2017年1月1日至2018年12月31日被转诊至我们科室。通过计算白蛋白、CPR(C反应蛋白)、全血细胞计数(中性粒细胞、淋巴细胞、血小板、血红蛋白)以及其他一些反映炎症状态的指标,即HALP综合指数、血小板与淋巴细胞比值(PLR)、中性粒细胞与淋巴细胞比值(NLR)、全身免疫炎症指数(SII)和晚期肺癌炎症指数(ALI),来研究患者的术前炎症状态。随访于2021年11月结束。使用Kaplan-Meier方法评估患者的总生存率。采用对数秩检验比较生存率。在单因素分析中与生存显著相关的变量被纳入Cox多因素分析(逐步模式)以评估其独立性。计算风险比及其95%置信区间。与<0.05相关的变量被认为具有显著性。:我们的研究纳入了257例患者。该队列的总生存率如下:1年,96.1%;3年,81.3%;4年,74.2%。单因素分析显示总生存的危险因素如下:胸科手术评分≥2(=0.002);组织学类型(=0.002);HALP<32.2(=0.0002);SII≥808.9(=0.0004);ALI<34.86(=0.0005);NLR≥2.29(=0.01);血红蛋白<13g/dl(=0.01);PLR≥196.1(=0.005);pN+(<0.0001);胸膜侵犯(=0.0002);以及存在血管或淋巴管肿瘤栓子(=0.0002)。多因素Cox分析(逐步模型)确定胸科手术评分≥2(=0.02)、组织学类型、HALP<32.2(=0.004)和pN(<0.0001)为死亡的独立预测因素。术前炎症状态对受非小细胞肺癌影响并接受手术的患者的长期预后有强烈影响。